Introduction
Src kinase family members, a group of non-receptor tyrosine kinases, simultaneously activate multiple signaling pathways including those mediating cell cycle progression and cytoskeletal organization (reviewed in Brown and Cooper, 1996; Taylor and Shalloway, 1996; Thomas and Brugge, 1997) . Dysregulation of Src via post-translational modifications or genetic alterations leads to constitutive kinase activity and cellular transformation (reviewed in Bjorge et al., 1995; Brown and Cooper, 1996; Jove and Hanafusa, 1987; Martin, 2001; Taylor and Shalloway, 1996; Thomas and Brugge, 1997) . Cellular Src (c-Src) differs from the viral oncoprotein v-Src at a handful of amino acids throughout the protein and at the negative carboxy terminus where 19 critical amino acids of c-Src have been replaced with 12 unrelated amino acids in v-Src (Takeya and Hanafusa, 1982) . These differences render v-Src constitutively active and highly transforming. vSrc transformed cells, but not c-Src overexpressing cells, have the ability to form tumors in nude mice (Johnson et al., 1985) . Other activating mutations have been described that increase Src kinase activity and transforming potential, including a stop codon mutation at amino acid 531 (Irby et al., 1999; Jove et al., 1989; Kato et al., 1986; Levy et al., 1986) . As such, Src activation has been implicated as an early event in colorectal carcinogenesis (Iravani et al., 1998) , where over 80% of colon cancers have elevated Src activity (Talamonti et al., 1993) , as well as in other gastrointestinal cancers (Kumble et al., 1997; Lutz et al., 1998; Takekura et al., 1990) .
The introduction of a single oncogene into established rodent fibroblast cell lines, is sufficient to produce transformation (Muschel et al., 1985; Parker et al., 1984) . However, a systematic genome-wide assessment of downstream targets at the level of mRNA expression has not been forthcoming (but see Zuber et al., 2000) . Furthermore, whether or not these altered expression patterns in rodent cell lines accurately reflect early changes in human tumorigenesis remains unclear. To address these issues, we examined numerous 3Y1 clones transfected with c-Src, v-Src, or Src531, a human Src mutant containing a truncating mutation at Tyr531 that is activating, moderately transforming and tumorigenic (Irby et al., 1999) . These clones represent the full spectrum of transformation potentials as determined by growth in soft agar. We correlate gene expression patterns with the acquisition of a transformed phenotype and validate an in vitro rodent cell line model of cellular transformation using gene expression patterns from human colon cancer samples, in which Src is thought to play a dominant role.
Results
Microarray data corroborates previously reported Src-regulated genes in cell lines transformed by pp60 v-src As a positive control, our rat array included a number of genes that are well-established to be either up-or down-regulated by v-Src (Supplemental Data Table 1 at http://pga.tigr.org/PGApubs.shtml). In corroboration with earlier reports, HIF-1, cathepsin L and cyclin D1 transcripts were upregulated by v-Src, while MARCKS, fibronectin and drs transcripts were downregulated. These expression profiles are consistent with the known biology of these genes during cancer progression. Of note, drs suppresses v-Src transformation in fibroblasts (Inoue et al., 1998) and suppresses anchorage-independent growth in a variety of human cancer cell lines (Yamashita et al., 1999) . MARCKS overexpression partially reverts the transformed phenotype of melanoma cells (Manenti et al., 1998) , and fibrosarcoma cells overexpressing fibronectin lose the ability to grow in soft agar (Akamatsu et al., 1996) . As such, some genes that are down-regulated by v-Src are potential tumor suppressor candidates. We have identified a number of novel genes (47) that are down-regulated by v-Src which may serve as new targets for cancer prevention. (Supplemental Data  Table 2 at http://pga.tigr.org/PGApubs.shtml).
Index of transformation
To assess transformation potential of the cell lines in this study we utilized two indices: total cellular protein phosphotyrosine levels and anchorage-independent growth in soft agar suspension. Phosphotyrosine and Src protein levels were measured from the lysates of parental 3Y1 cells, and 3Y1 cells transfected with cSrc, Src531 or v-Src (Figure 1a) . Total phosphotyrosine levels in Src transfected cells increased 2 -15-fold over parental levels with the following rank order: v-
. Src Western blots demonstrate that c-Src, Src531 and v-Src transfectants has an average elevation in the 60 kDa Src protein of 2.6-, 3.0-and 2.1-fold, respectively.
Anchorage-independent growth of fibroblasts stably transfected with c-Src, Src531 or v-Src was measured by colony formation assays in soft agar ( Figure 1b) . As noted previously (Irby et al., 1999) , both Src531 and vSrc expression produced significant numbers of colonies in soft agar (t-test; P50.05, n=4 -8) although colonies formed by Src531 were notably smaller than colonies formed by v-Src over the same period of time. In contrast, c-Src overexpression produced a very low number of small, slowly developing colonies over an extended period of time (inset). The number of colonies formed by c-Src transfectants was on average, 13-fold less that the number of colonies formed by the two distinct v-Src transfectants (t-test; P50.05, n=4 -6). It should be noted that growth in soft agar measured anchorage-independent growth and not proliferation rates. All transfectants had similar doubling times when grown as monolayers in tissue culture dishes (data not shown). The following rank order was observed for colony formation:
No soft agar colony formation was observed in any of the 3Y1 parental cell lines (data not shown).
Cluster analysis reveals correlation between gene expression patterns and transformation indices
To identify groups of genes on the basis of similarities in the pattern with which their expression varied across the Src-transfected cell lines, we applied two-dimensional hierarchical clustering (Eisen et al., 1998) to log 2 -transformed, median centered, normalized expression ratios for each gene using a Pearson correlation coefficient distance metric. The final dataset was filtered to retain only those genes that had reported expression values in at least eight of the nine lines examined. The dendrogram shown in Figure 2a illustrates the segregation of cell lines into three major branches. Of interest, these expression groupings precisely matched our phenotypic groupings based on overall tyrosine kinase activity and soft agar colonization (Figure 1 ). The leftmost green branch contains the three c-Src cell lines with the lowest transformation potential. The rightmost red branch segregates the cell lines (Src531 M1, Src531 M3, v-Src A and v-Src B) with the highest transformation potential, while the middle black branch groups the two Src531 cell lines with an intermediate transformation potential, M14 and M18. We then applied principal component analysis (PCA) (Alter et al., 2000; Raychaudhuri et al., 2000) to the cell experiment vectors. PCA is a mathematical technique used to reduce the dimensionality of our data by identifying subsets of gene expression profiles that were responsible for the majority of variance among the cell lines. Principal components are typically ordered based on their information content so that the first three components contain most of the variability. With PCA, phenotypic differences in cell lines can be easily visualized as a function of expression profiles and plotted on x, y, and z coordinates. Consistent with hierarchical clustering, there was a clear separation between the low transforming cell lines (green spheres) and the highly transforming cell lines (red spheres) (Figure 2b ). Hierarchical clustering on the gene axis identified subsets of co-regulated genes that correlated with our Src transformation indices (Supplemental Real time PCR analysis of gene expression was performed on an ABI Prizm 7700 Sequence Detection System using SYBR green. The expression of the housekeeping gene, cyclophilin 33A, was used for normalization. Cyclophilin 33A did not exhibit differential expression in our microarray assays. Real time PCR values are mean+s.d. (n=3). Microarray analysis of gene expression (n=1) was performed using the HuU95A GeneChip TM (Affymetrix). Stained chips were scanned on a GeneArray TM Scanner (Affymetrix, Santa Clara, CA, USA), and data files were processed as summarized by GeneChip TM software protocols. Data are extracted from one analysis. Real-time PCR and Microarray expression values are expressed as a fold change from normal mucosa. Gene accession numbers are in parentheses Data Figure 1 at http://pga.tigr.org/PGApubs/shtml). Highly similar groupings (490% conservation of genes between the two methods) were also identified through k-means clustering for the larger clusters. Figures of merit were calculated for various values of k as a measurement of cluster quality (Yeung et al., 2001) . A gradual decline in FOM was seen between k=10 -20 and FOMs leveled off after k=20, indicating that the optimal k lies near 20 clusters. FOMs for k=20, 25 and 30 were 0.898+0.15, 0.693+0.18 and 0.645+0.08 respectively (n=25). These results demonstrate that for the larger stable clusters, both algorithms generate consistent partitions that are robust and independent of k (data not shown). The genes in these subsets were consistently under-represented in the weakly transformed c-Src cell lines and over-represented in the highly transformed Src531 M1, Src531 M3 and v-Src lines (Supplemental Data Figure 1 at http://pga.tigr.org/PGApubs.shtml). We are tentatively calling this pattern of 648 unique co-regulated genes, distributed across several related clusters, a 'transformation fingerprint'. This pattern contains genes involved in various cellular processes including cell growth and regulation, signal transduction and protein degradation. Several dozen hypothetical proteins and proteins with unknown functions were also grouped within this fingerprint.
In addition, we were able to identify a small cluster of genes that were over-represented in the weakly transformed c-Src cell lines and under-represented in the highly transformed cell lines. This cluster partitioned consistently by k-means and CAST (Ben-Dor et al., 1999) . However, we chose to focus our subsequent analysis on the larger gene clusters.
Src-regulated genes that overlap genes in colon cancer
In order to determine whether the transformationassociated genes identified using the rat fibroblast model are relevant in human colon cancer, we compared expression ratios of orthologous genes present in both the rat cDNA array and Affymetrix Hu95A GeneChip TM . The latter array was used to interrogate a dataset derived from the normal colon and 50 staged colon tumors progressing from adenomas to Duke's B1, C2 and D to metastasis. Using the TIGR Orthologous Gene Alignment (TOGA) database (Lee et al., 2002) , http://www.tigr.org/tdb/tgi/ego/ index.shtml, we extracted human orthologs for each gene present in out 'transformation fingerprint'. TOGA is constructed from pair-wise comparisons of the tentative consensus sequences that comprise the TIGR Gene Indices (Quackenbush et al., 2000) . Tentative orthologs were identified by transitive reflexive best hits between two or more species with a maximum BLASTIN e-value of 10 75 . Reciprocal best matches between human and rat identify tentative orthologs. Out of the overlapping set of 356 orthologous genes, 206 genes (58%) had reported expression values in 90% of the combined human tumor and rat cell line datasets. We applied hierarchical clustering to these 206 orthologous genes (Figure 3 ; Supplemental Data Table 3 at http://pga.tigr/org/PGApubs.shtml). Nearly 40% of the genes (82 total, 73 unique) had expression patterns that correlated between the cell lines and tumor samples. These findings demonstrate that our transformation fingerprint was able to predict dysregulated genes in colon tumors and thus provide candidate genes that may be involved in cancer progression. A notable property of the clustered data was the finding that the colon tumor samples were more closely related to the highly transformed Src cell lines (v-Src A and B, Src531 M1 and M3) than the weakly transformed lines using this specific genes set as a discriminator. Moreover, when we applied hierarchical clustering to a set of 850 orthologous genes not in the transformation fingerprint, no clusters arose where the cell line data allowed us to predict expression patterns in the tumors and 51% of the cell line genes correlated with the tumor data (P50.05; w 2 test). This indicates the significance of our 'transformation fingerprint'. Principal component analysis of the cell experiment vectors using genes outside of the fingerprint resulted in more disperse distribution of the tumors and cell lines than seen with genes within the transformation fingerprint, reinforcing that the set of genes in the 'transformation fingerprint' are highly correlated (data not shown).
Reversed expression of Src regulated genes by a pharmacologic inhibitor
We used the tyrosine kinase inhibitor, PD180970, a pyrido[2,3-d]pyrimidine ATP-competitive inhibitor of c-Src kinases (Kraker et al., 2000) , to inhibit Src activity in Src531 M3. Inhibition of Src kinase activity was confirmed by enolase assay (4threefold decrease in Src activity, n=2), and subsequently diminished growth in soft agar (data not shown), demonstrating a reversal in transformation potential. The gene expression pattern of inhibitor treated Src531 M3 grouped away from untreated M3 cells and was highly related to the weakly transforming c-Src transfectants, as indicated by hierarchical analysis (Figure 3 ). These findings support the view that a loss in transformation potential is accompanied by a reversal in the transformation fingerprint.
Confirmation of array data by RT -PCR analysis of colon tumors
We have confirmed the up-regulation of 14 genes in the transformation 'fingerprint' by real time PCR. The genes examined for confirmation were purH, IGFBP-3, lysyl hydroxylase, Ubc 12 and 13, Ube2i, KIAA0459, tumor protein D52, annexin V, catecholamine-Omethyltransferase, bumetanide-sensitive Na-K-Cl cotransporter, beta-1,4-galactosyltransferase, nucleosome assembly protein and proteasome component RC1 (Table 1) .
Discussion
Activated expression of Src occurs in 80% of all human colon tumors (Talamonti et al., 1993) and is implicated in the development and progression of several other types of human cancers (Kumble et al., 1997; Lutz et al., 1998) . Understanding the mechanisms which allow a cell to progress from a normal growth state to a transformed state is facilitated by documenting the molecular changes occurring during transformation development. We have employed a spotted cDNA microarray platform to analyse a panel of nine fibroblast cell lines transfected with three v-Src (two cell lines). Approximately 600 co-regulated genes were identified that correlated with high tyrosine kinase activity and soft agar colonization. This 'transformation fingerprint' is composed of five gene clusters containing between 21 -306 genes/cluster. Another *1600 differentially regulated genes were identified in our cell line model. However, these elements did not fall into characteristic patterns (via HCL or PCA; data not shown) that correlated with any of our transformation indices. While these genes may be Src regulated they are not likely to play a significant role in transformation. In the fingerprint, the more highly transformed cell lines expressed genes that are upregulated as compared to the weakly transformed cell lines. Overall, the moderate 2 -4-fold reported changes in differential gene expression were anticipated as these lines are stable transfectants, not induced. In general, larger fold changes in gene expression are expected under acute induction, like serum stimulation, than under stable growth conditions. Nonetheless, 7% of the arrayed genes, exhibited changes in excess of fourfold. Tyrosine kinase activity is low in normal fibroblasts (50.05% of total phosphorylated amino acids (Sefton et al., 1980) ), and overexpression of pp60 c-src generally does not grossly transform cells (Iba et al., 1984; Johnson et al., 1985; Parker et al., 1984; Shalloway et al., 1984) . While full transforming ability of v-Src requires simultaneous activation of multiple signaling pathways (Odajima et al., 2000) , we hypothesized that the c-Src, Src531 M14 and M18 lines expressing limited Src activity do not sufficiently activate the multiple pathways required for full transformation. The lack of full transformation may be reflected by an under expression of genes in the 'transformation fingerprint'. Support for this idea is demonstrated by the pharmacological inhibition of Src in the highly transformed Src531 M3 cell line. These Src-inhibited M3 cells exhibit a low transformation potential and underexpression of genes in the 'transformation fingerprint'. The combination of our 'transformation fingerprint' along with a decades old in vitro cell line model for transformation may provide an early screening for the utility of chemotherapeutic drugs at the preclinical stage. Clearly, expression profiling of cell lines transformed with different classes of oncogenes will refine and perhaps identify distinct categories of co-regulated genes associated with different tumors or tumor stages.
Since expression data derived from in vitro cell lines may not accurately reflect the in vivo molecular events that occur in a complex tissue milieu, we crossvalidated our 'transformation fingerprint' against a panel of colon tumor tissues. A number of interesting genes (73) were found to be upregulated in both the highly transforming Src-transfected cell lines, as well as in the human colon tumors. Several genes are known to be involved in Src signaling as well as transformation. Upregulated genes coded for proteins that could be grouped into the following eight functional categories: transcription factors and RNA processing, chaperonins and heat shock proteins, cell growth and proliferation, lysosomal components, signal transduction, cytoskeletal organization and intracellular trafficking, ubiquitin and proteasome pathway components and proteins with unknown function. Figure 3 Cluster analysis of orthologous genes in the 'transformation fingerprint'. We applied two-dimensional hierarchical clustering to log (base 2) transformed expression ratios for each orthologous gene expressed in rodent cell lines and human colon tumors using an Euclidean correlation coefficient distance metric. Shown is the Clustergram of the 82 genes that corroborate the rodent cell line model's ability to predict human colon tumor expression patterns. The dendrogram at the top demonstrates the relationship between the Src-transfected cell lines and the tumor stages. The color of the gene name indicated its assigned functional role Transformation leads to aberrant up-regulation of cell cycle control genes Fibroblasts, as a part of normal cellular functions, exhibit tight regulatory control over the cell cycle and thereby maintain normal cell proliferation rates. Cyclins, heat shock proteins and the ubiquitin system maintain an orderly, unidirectional transition through the cell cycle. Transformed cells exhibit aberrations in cell cycle control and such alterations have been associated with tumor progression. We document in both patient tumors and highly transformed cell lines the up-regulation of numerous transcripts encoding proteins that regulate cell cycle transition. Cyclin G, up-regulated in our Duke's D and metastasis samples, is also overexpressed in human osteosarcoma, breast and prostate cancer cells (Reimer et al., 1999; Skotzko et al., 1995) . Hsp90, and cyclin D1 transcripts are significantly higher in breast cancer tissues than in noncancer tissues (Yano et al., 1999) . Cyclin D1 and Hsp90 were elevated 2 -3-fold in all five stages of colon cancer examined. Both ubiquitin conjugating enzymes, Ubc12 and Ube2i, were overexpressed in colon tumors as compared to normal mucosa, in agreement with their reputed cellular roles in proliferation.
Cytoskeletal proteins associated with actin-based motility or intracellular transport are overexpressed in tumors
Transformation of eukaryotic cells by Src is associated with alterations in cytoskeletal organization (Wickus et al., 1975) . v-Src transformed 3Y1 fibroblasts have poorly organized stress fibers and reduced amounts of a actin (Okamoto- Inoue et al., 1990) . Using our 'transformation fingerprint', we identified several dysregulated genes involved in maintaining cell structure, shape and motility that were up-regulated in both the highly transformed cell lines and human colon tumors. Lasp-1, a novel actin-binding protein that is amplified in breast tumors (Schreiber et al., 1998) , is postulated to play an important role in the regulation of dynamic actin-based, cytoskeletal activities (Chew et al., 2000) . APP-1 was recently suggested to play a role in actin based cell motility (Sabo et al., 2001 ) and has been implicated in cell adhesion and proliferation . Neuroleukin is an autocrine motility factor that regulates invasion and metastasis. Overexpression and selected secretion occurs in tumor cells but not normal counterparts (Niinaka et al., 1998) . Neuroleukin expression was highest in v-Src A and Src531 M3, rodent cell lines that display high invasive activity as measured by matrigel and in vivo assays (Irby et al., 1999) . Several transcripts for proteins not previously known to be upregulated in colon cancer were identified, including dystroglycan, dynein, and myosin-IXb. In addition, several transcripts for endosomal/lysosomal proteins were also found to be up-regulated in transformed cells and patient tumors, including VAMP-7, Munc-18, man-6-P/IGF-II receptor, Gm2 activator protein, endolyn and arylsulfatase. Of these, only man-6-P/IGF-II receptor expression has been shown prior to our study to be elevated in malignant colon tissue (Freier et al., 1999) . The altered expression of genes involved directly or indirectly in cytoskeletal organization and protein trafficking suggests an important role in transformation and invasion.
Potential novel therapeutic targets identified
We have identified potential new targets for colon cancer detection and/or intervention using a combination of in vitro and in vivo expression studies. D52 tumor protein was originally identified as being over expressed in breast tumors (Byrne et al., 1995) and belongs to a novel family of potential regulators of cellular proliferation. We report the upregulation of D52 occurs in colon tumors and by cells overexpressing Src. P311 encodes an abundant embryonic brain protein of unknown function (Studler et al., 1993) and is upregulated in our colon tumor samples. Moreover, we have identified a number of additional transcripts represented by ESTs that show elevated expression in transformed cells and colon tumors and appear to be novel with undocumented functions or tissue expression patterns (e.g., RGIAF09, RGIAK44, RGIAQ59, RGIAX14, TGIBA64, RGIBC21, RGIBC48, RGIBF59, RGIBY11, RGICB21, RGICE78). As these genes are downregulated in the presence of the Src inhibitor, they provide attractive starting points for future research into the biology of tumor progression. Microarray analysis provides a mechanism to functionally annotate these novel sequences, which is particularly relevant considering that the majority of EST sequences have unknown cellular roles.
Conclusions
We validated the utility of a classical fibroblast model of cellular transformation to successfully predict human tumor biology. We have demonstrated, for the first time, using a cross-platform analysis, that a Src-transformation pattern can be identified in human colon tumors. This pattern is richly populated by genes in multiple functional classes including transcription factors, signal transduction factors, and proteins linked to intracellular trafficking and cell proliferation. As such, these genes make interesting targets for drug development aimed at inhibiting tumor development and progression. These data, taken together with the known high frequency of Src activation in human colon cancer, strongly suggest a role for Src in the development and progression of this disease. Furthermore, with the identification of numerous surrogate markers, Src may now be a valid target for drug discovery.
Materials and methods

Cell culture
Generation of the 3Y1 rat fibroblast cell lines used in this study were described previously (Irby et al., 1999) . Multiple transfected clonal lines for each Src construct were analysed by microarray analysis. For soft agar assays, equal numbers from each 3Y1 cell line were seeded in 0.5% low melt agarose and incubated for 3 -5 weeks until colonies were formed and counted. Cells were treated with PD180970 (50 nM) for 18 h where indicated.
Amplification of cDNA clones from the TIGR Rat Gene Index
We selected 4320 clones from the TIGR Rat Gene Index collection and an additional 16 clones were obtained from Research Genetics (Huntsville, AL, USA). Selection of clones for arraying is described elsewhere (Miller et al., 2001) . The complete set of clones in the TIGR Rat Gene Index can be queried at 5http://www.tigr.org/tdb/rgi/index.html4. The full list of annotated RGI clones arrayed in this report (2192) is located at 5http://www.tigr.org/tdb/ratarrays/ index.htnl4. In addition, 2039 clones had 5'-EST sequences that did not have significant matches to non-EST sequences in Genbank. We have sequence verified 93% of the total arrayed clone set. There is *5% redundancy of arrayed clones for quality control.
Production of cDNA microarrays
Microarrays were fabricated by robotically printing purified PCR products onto poly-lysine coated glass slides (DeRisi et al., 1997) . Arrays were printed using either a GeneMachine arrayer (San Carlos, CA, USA) or an Intelligent BioInstruments Arrayer (Cambridge, MA, USA). Arrays were post-processed to block free amine groups and immobilize the DNA (DeRisi et al., 1997).
Probe preparation and hybridization
To minimize differences in RNA expression resulting from plating variations, a minimum of five 150 mm tissue culture dishes were used to isolate total RNA from sub-confluent 3Y1 cell lines. Total RNA was prepared using TRIzol Reagent as per the manufacturer's protocol (Life Technologies, Grand Island, NY, USA). We combined equal concentrations of total RNA from the following independent parental cell lines to make the reference 3Y1 pool: 3Y1_a, 3Y1_b, 3Y1_1987.
For each comparative hybridization, labeled cDNA was synthesized from a minimum of 25 mg total RNA from the test cell lines (Src containing cell lines) in the presence of Cy5-dUTP, and from an equal amount of total RNA from the reference 3Y1 pool in the presence of Cy3-dUTP using a Superscript II reverse transcriptase kit (Life Technologies). Alternatively, the dyes were reversed to check for any bias in labeling. Probe labeling, purification and hybridizations were performed and are previously described (Guo et al., 2000) .
Image scanning and cluster analysis
Fluorescence intensities were measured at 10 mm per pixel resolution (GenePix Pro 4000A, Axon Instruments, Inc., Foster City, CA, USA). Differential expression was determined as the background subtracted Ratio of Median intensities (635 nm emission/532 nm emission) from the two channels. The following parameters identify well measured features: feature diameter 450 mm; saturated pixels 550%; sum of background subtracted median intensities for each wavelength 41500 units (scale of 0 -65 535). The median feature intensity (532 nm) vs the median feature intensity (635 nm) was plotted for well measured features meeting the above requirements and the regression was used to normalize the ratio data. Where features were observed on multiple arrays, the feature's normalized ratio values were averaged. Features that were not observed on at least three arrays were excluded from further analysis. Our final dataset consisted of 2477 elements.
For data analysis, we used TIGR MultiExperimentViewer (TMEV), available at: 5http://www.tigr.org/softlab/4. Before clustering, logarithms (base 2) were calculated for the measured median fluorescence ratio for each gene (n=3 -5). Logarithms were then median centered to make the analysis independent of the amount of a gene's transcript present in the reference pool. The Pearson correlation coefficient was used as the measure of similarity with average linkage clustering.
Affymetrix Hu95A GeneChip
TM
The Hu95A GeneChip TM (Santa Clara, CA, USA) contains over 12 000 probe sets corresponding to 8900 named genes (UniGene Build 139). Human tissues were derived from normal mucosa (n=10), adenomas without evidence of cancer (n=10), modified Astler-Collier (AC) stage B1 cancers (partial thickness invasion, node negative) (n=10), AC stage C2 cancers (full thickness invasion, node positive) (n=10), AC stage D cancers (primary tumor metastatic to distance organs) (n=10), and resected liver metastatic foci (n=10). For each sample, total RNA was prepared by TRIzol (Invitrogen, Carlsbad, CA, USA) extraction, quantified, and validated for integrity by gel electrophoresis. Samples were pooled in equimolar amounts (10 samples/pools). Target synthesis, hybridization, and post hybridization staining were performed using standard protocols as recommended by the manufacturer (Affymetrix). Stained chips were scanned on a GeneArray TM Scanner) Affymetrix, Santa Clara, CA, USA), and data files processed, as summarized by GeneChip TM software protocols.
Western analysis
Cells were grown in 100 mm tissue culture dishes to 75% confluency, harvested/lysed in 958C SDS -PAGE sample buffer and proteins were separated as described previously (Lee and Malek, 1998) . Blots were probed with an antiphosphotyrosine antibody (Upstate Biotechnology, Lake Placid, NY, USA) to assess tyrosine kinase activity in cellular lysates. Blots were stripped, reprobed with anti-Src, clone GD11 antibody (Upstate Biotechnology) to assess Src expression levels. Image analysis and quantification was performed using Quantity One (BioRad).
Real-time PCR
Pooled RNA from human tumors was reverse transcribed using random primers as per manufacturer's protocol (Life Technologies). The resulting cDNA was diluted and used as template for RT -PCR. PCR primers were selected for specificity by NCBI BLAST of the human genome and amplicon specificity was verified by first derivative melting curve analysis using the software provided by Perkin-Elmer/ Applied Biosystems. Analysis of gene expression was performed on an ABI Prizm 7700 Sequence Detection System using SYBR green. The expression of the housekeeping gene, cyclophilin 33A, was used for normalization. Cyclophilin 33A did not exhibit differential expression in our microarray assays. Sequences for the PCR primer pairs for each gene are as follows: cyclophilin 33A, GACTGTGGGGAGTA-
